iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Torrent Pharma promoter to pare 2.9% stake via block deal

30 Oct 2024 , 11:48 AM

Torrent Pharmaceuticals’ promoter is expected to sell a 2.9% share in the firm worth ₹3,000 Crore in a block auction on Wednesday. The promoter is set to issue 8.27 million shares at a discount of 6% per equity share over the current market price, according to reports.

This will include a greenshoe option of 1.65 lakh shares, which represents 0.5% of the equity.

According to the article, Kotak Securities and Citigroup will most likely serve as bankers for the Torrent Pharma transaction.

Torrent Pharma shares closed Tuesday’s session at ₹3,207 on the NSE, down ₹109.70 or 3.31% from Monday’s closing price.

Torrent Investments Private Limited is the company’s promoter, having a 71.25% interest as of September 30, 2024.

Torrent Pharmaceuticals reported a consolidated profit after tax (PAT) of ₹453 Crore in the September quarter, up 17% on strong domestic sales. The drug company declared a PAT of ₹386 Crore for the July-September period of the previous fiscal.

Torrent Pharmaceuticals said in a regulatory filing that revenues increased to ₹2,889 Crore during the reviewed period, up from ₹2,660 Crore the previous year.

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies. 

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Torrent Pharma
  • Torrent Pharma Block Deal
  • Torrent Pharma News
  • Torrent Pharma Updates
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp